Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share (Tables)

Net Income (Loss) Per Share (Tables)

6 Months Ended

Jun. 30, 2017

Reconciliation of Numerator and Denominator

A reconciliation of the numerator and denominator used in the calculation is as follows (in thousands, except per share amounts):

	Three Months Ended June 30,					Six Months Ended June 30,
	2017		2016			2017			2016
Numerator:
Net income (loss)	$	1,145	$	(6,864	)	$	(3,929	)	$	(14,716	)
Denominator:
Weighted average common shares outstanding - basic		71,592		71,511			71,584			71,500
Dilutive effect of equity incentive awards		29		—			—			—
Weighted-average common shares outstanding and dilutive potential common shares — diluted		71,621		71,511			71,584			71,500
Net income (loss) per share:
Basic	$	0.02	$	(0.10	)	$	(0.05	)	$	(0.21	)
Diluted	$	0.02	$	(0.10	)	$	(0.05	)	$	(0.21	)

Warrants, Options and Purchase Rights Excluded from Computation of Diluted Net Loss Per Share

The following outstanding warrants, options and purchase rights under the Company’s 2004 Employee Stock Purchase Plan (“2004 Purchase Plan”) were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2017		2016		2017		2016
Shares issuable upon exercise of warrants		8,300		8,300		8,300		8,300
Shares issuable upon exercise of stock options		10,542		11,635		10,732		11,635
Shares issuable related to the 2004 Purchase Plan		21		42		21		42